focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
BDfox,
Well put.
Like most I also expected the fuel crisis to boost companies such as AFC, but unfortunately in these insecure times, companies are very reluctant to invest for the future, even if they accept/believe that such investments are the best way forward.
Fear of further risk, re both the war in Ukraine escalating accompanied by the obvious decreasing world GDP (mainly China) is the main obstructing factor to investment.
Things will improve, perhaps getting worse before they do and that will have a positive and dramatic view on almost all stocks, especially those such as AFC which are part of the future of power technology providers.
Hi Cornishknocker,
I like Freo find the jargon difficult to understand, and I consider myself sufficient in such financial parlance to understand most financial meanings.
The basic you have rightly explained, but the RNS as a whole is confusing to say the least.
I think the shareholders have asked a lot more important questions than 'are the company still intending to grow by acquisition.'
The company should be updating us in many areas.
Hi Fireblade,
But the showing spread before you put in any deal, test or otherwise is far higher, which is often what punters look at, then due to seeing a higher spread do not bother to seek a quoted price.
Not posted for a while, but my thoughts (probably wrong) are that as MM's have to make a living, they obviously do so by increasing the spread when a companies shares have a low number of dealings, and shorten the spread when demand to deal goes up.
So looking at the demand over the last few trading days, to sell or/and buy, I can't see any reason to have such a large spread today other than they want to fill a big order.
This large spread is more likely holding buyers/sellers back, than MM's holding reporting on dealings back, which sometimes happens, but not often to any great extent.
As to whether that order is a buy or sell, I have no idea.
Time will obviously show if I am right or wrong.
Can anyone recommend a company for Level 2.
I presently have Level 2 with LSE, but more often than not my Stockwatch does not correlate to my portfolio, often showing a SP up on my stockwatch, but same company down in my portfolio.
Thanks.
Can anyone recommend a company for Level 2.
I presently have Level 2 with LSE, but more often than not my Stockwatch does not correlate to my portfolio, often showing a SP up on my stockwatch, but same company down in my portfolio.
Thanks.
Bad spelling/grammar do not always indicate low intelligence.
My spelling is atrocious (dyslexic) , but I am a member of Mensa with an IQ of 147/148.
Sooner read a post full of spelling and grammatical mistakes that has good content, than a nonsensical post that is correctly spelt with good grammar.
Once the users get used to Feedbacks technology, it will be like mobile phone use, IE likely to become a must have.
Until a better technology comes along which will probably take years, resulting in good returning/repeat revenue for Feedback.
Looks reasonable, although a not sp busting contractual amount, but I can't see and reason why over the next 12/18 months many other NHS Trusts won't also sign on the dotted line.
With a total of 219 NHS Trusts in total, at the same amount average per contract that's £21,900,000, with what must be a very high profit margin over cost.
From the ABB Web Site.
ABB offers a total EV charging solution from compact, high quality AC wall boxes, reliable DC fast charging stations with robust connectivity, to innovative on-demand electric bus charging systems, we deploy infrastructure that meet the needs of the next generation of smarter mobility. NOTE.... all their current solutions are via the grid.
They state that they have the worlds fastest charger (Tera Unit).
If you boast the worlds fastest on grid EV charger and you are looking to add an off grid charging unit to your portfolio, you would obviously go for what you consider is the best fit.
Great news, with I am sure more to follow in the next few months.
This is still a very small company with a Mkt Value of £18 million, in fact its more than small, its almost miniscule.
As it is such a small company, even on AIM terms, it is not just un investible for most institutional investors, it is not on the radar of many small investing PI's, both reasons of why the sp is held back, or even as we see today, knocking the sp back after what to me looks like an sp boosting RNS.
If I had a few quid spare, I would be looking to increase my holding, but still happy to sit tight and look towards the next 12 months.
Being an IT based company, as soon as a customer signs up, the ball rolls, different to a produce producing company that has to manufacture and ship out the bought product..
As Vasular says, some bits really stand out.
So first patient through, no doubt first of many But the main point has to be ........'The pilot, run in partnership with Qure.ai and Amazon Web Services will now move into an evaluative stage where the system benefits will be measured as patients come through'.
Meaning, that the tech works out in the real world (as we knew) but now requires to show proof to the world, that it works when maximising upward re number of patients going through the tech process (no reason why it should not).
In parallel the Company will pursue a number of opportunities to commercialise the system, leveraging the evidence generated by the pilot.
Meaning other potential customers already lined up and no doubt already jump on board.